Nabriva Therapeutics
-$0.05 (-3.52%) Today
+$0.05 (+3.65%) As of 12:00 AM UTC after-hours
Why Robinhood?
You can buy or sell NBRV and other stocks, options, and ETFs commission-free!
About NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland, also called Nabriva Therapeutics, is a biopharmaceutical company, which engages in the research, development, and commercialization of novel anti-infective agents to treat serious infections. Its product pipeline includes Lefamulin, and CONTEPO.
CEO
Theodore R. Schroeder
Employees
72
Headquarters
Dublin, Dublin
Founded
2005
NBRV Key Statistics
Market Cap
50.23M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
734.91K
High Today
$1.44
Low Today
$1.36
Open Price
$1.37
Volume
446.50K
52 Week High
$12.00
52 Week Low
$1.31
NBRV Earnings
-$0.67
-$0.45
-$0.22
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
-$0.67 per share
Actual
-$0.53 per share